Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd R Burmester, Yannick Palmowski, Maarten Boers, John H. Stone, Christian Dejaco, Frank Buttgereit
Topics & Concepts
MedicineInternal medicineOsteoporosisRheumatoid arthritisConfoundingPrednisoneBone mineralRheumatologyDoseCohortDosingGastroenterologyBone health and osteoporosis researchRheumatoid Arthritis Research and TherapiesBone Metabolism and Diseases